ℹ️
🇬🇧
Search
Search for publications relevant for "iLLUMINATE trial"
iLLUMINATE trial
Publication
Class
Person
Publication
Programmes
publication
First-line treatment of chronic lymphocytic leukemia with ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab: final analysis of the randomized, phase 3 iLLUMINATE trial
2022 |
Faculty of Medicine in Hradec Králové, Third Faculty of Medicine